Pacira Survey Reveals Widespread Pain Impact on U.S. Workforce
Event summary
- Pacira BioSciences released a national survey of 1,000 U.S. workers in physically demanding jobs, revealing 85% experience pain at work.
- Knee pain was the most common complaint, with 73% of respondents reporting it and 56% experiencing chronic knee pain.
- 46% of workers said pain prevented career advancement opportunities, while 98% expressed interest in long-lasting non-opioid treatments.
- The survey was conducted between April 17 and May 3, 2026 by Wakefield Research.
The big picture
Pacira's survey highlights a significant unmet need for effective, long-lasting pain management solutions among workers in physically demanding jobs. This positions the company to capitalize on growing demand for non-opioid therapies as awareness of chronic pain impacts increases. The findings could also influence workplace policies and healthcare provider approaches to treating orthopedic pain.
What we're watching
- Market Opportunity
- How Pacira will leverage these findings to expand adoption of its non-opioid pain management solutions.
- Regulatory Dynamics
- Whether increased awareness of chronic pain issues will accelerate approval processes for new treatments.
- Competitive Positioning
- The pace at which Pacira can differentiate itself from competitors in the non-opioid pain management space.
Related topics